Tafamidis: A Game Changer in Transthyretin Cardiomyopathy? A Systematic Review of Efficacy and Safety

被引：0
|
作者：
Hussain, Bilal
Hamza, Mohammad
Sattar, Yasar
Patel, Bansari
Song, David
Patel, Neel N.
Duhan, Sanchit
Cheema, Mustafa Sajjad
Naeem, Minahil
Waqar, Hafiza Hareem
Lactana, Sharaad
Alraies, M. Chadi C.
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Amyloidosis; Mortality; Heart Failure; Echocardiography;
D O I：
10.1161/circ.148.suppl_1.16556
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16556
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Effect of tafamidis on left atrial function of patients with transthyretin amyloid cardiomyopathy
    Uemura, Koya
    Ichikawa, Yasushi
    Nagai, Shun
    Nishihara, Yu
    Todo, Saki
    Oota, Eri
    Odajima, Susumu
    Takeuchi, Kimikazu
    Kintsu, Masayuki
    Fukuda, Terunobu
    Hisamatsu, Eriko
    Hirata, Ken-ichi
    Tanaka, Hidekazu
    HEART AND VESSELS, 2024, 39 (09) : 810 - 817
  • [22] A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis
    Waddington Cruz M.
    Benson M.D.
    Neurology and Therapy, 2015, 4 (2) : 61 - 79
  • [23] Causes of Cardiovascular Hospitalization and Death in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT])
    Miller, Alan B.
    Januzzi, James L.
    O'Neill, Blair J.
    Gundapaneni, Balarama
    Patterson, Terrell A.
    Sultan, Marla B.
    Lopez-Sendon, Jose
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 148 : 146 - 150
  • [24] Tafamidis for autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis: a review
    Cruz, Marcia Waddington
    CLINICAL AUTONOMIC RESEARCH, 2019, 29 (Suppl 1) : 19 - 24
  • [25] Tafamidis for autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis: a review
    Márcia Waddington Cruz
    Clinical Autonomic Research, 2019, 29 : 19 - 24
  • [26] Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy Further Analyses From ATTR-ACT
    Rapezzi, Claudio
    Elliott, Perry
    Damy, Thibaud
    Nativi-Nicolau, Jose
    Berk, John L.
    Velazquez, Eric J.
    Boman, Kurt
    Gundapaneni, Balarama
    Patterson, Terrell A.
    Schwartz, Jeffrey H.
    Sultan, Marla B.
    Maurer, Mathew S.
    JACC-HEART FAILURE, 2021, 9 (02) : 115 - 123
  • [27] Efficacy and safety of diflunisal therapy in patients with transthyretin cardiac amyloidosis (ATTR-CA): a systematic review and meta-analysis
    Huang, Wilbert
    Frederich, Alvin
    Nurhafizah, Apridya
    Salma, Antania Devita
    Zahrani, Rivera Adenia Firza
    Retnoningrum, Intan Aulia
    EGYPTIAN HEART JOURNAL, 2025, 77 (01)
  • [28] Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years
    Barroso, Fabio A.
    Judge, Daniel P.
    Ebede, Ben
    Li, Huihua
    Stewart, Michelle
    Amass, Leslie
    Sultan, Marla B.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2017, 24 (03): : 194 - 204
  • [29] Long-term survival in people with transthyretin amyloid cardiomyopathy who took tafamidis: A Plain Language Summary
    Elliott, Perry
    Drachman, Brian M.
    Gottlieb, Stephen S.
    Hoffman, James E.
    Hummel, Scott L.
    Lenihan, Daniel J.
    Ebede, Ben
    Gundapaneni, Balarama
    Li, Benjamin
    Sultan, Marla B.
    Shah, Sanjiv J.
    FUTURE CARDIOLOGY, 2023, 19 (01) : 7 - 17
  • [30] Efficacy and safety of cardiac resynchronization therapy in chemotherapy-induced cardiomyopathy: A systematic review
    Shehram, Muhammad
    Khalid, Hiba
    Shafique, Hafiz Muhammad
    Umer, Bakht
    Zafar, Awais
    Ullah, Asif
    Zaidi, Syed Muhammad Jawad
    Basit, Jawad
    Mehmoodi, Amin
    Malik, Jahanzeb
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2023, 28 (05)
12345